Bristol-Myers Squibb's market value is the price at which a share of Bristol-Myers Squibb trades on a public exchange. It measures the collective expectations of Bristol Myers Squibb investors about its performance. Bristol-Myers Squibb is selling at 1002.93 as of the 16th of February 2026; that is 0.29% up since the beginning of the trading day. The stock's last reported lowest price was 1000.0. With this module, you can estimate the performance of a buy and hold strategy of Bristol Myers Squibb and determine expected loss or profit from investing in Bristol-Myers Squibb over a given investment horizon. Check out Bristol-Myers Squibb Correlation, Bristol-Myers Squibb Volatility and Bristol-Myers Squibb Performance module to complement your research on Bristol-Myers Squibb. To learn how to invest in Bristol-Myers Pink Sheet, please use our How to Invest in Bristol-Myers Squibb guide.
It's important to distinguish between Bristol-Myers Squibb's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bristol-Myers Squibb should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Bristol-Myers Squibb's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Bristol-Myers Squibb 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bristol-Myers Squibb's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bristol-Myers Squibb.
0.00
11/18/2025
No Change 0.00
0.0
In 2 months and 31 days
02/16/2026
0.00
If you would invest 0.00 in Bristol-Myers Squibb on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Bristol Myers Squibb or generate 0.0% return on investment in Bristol-Myers Squibb over 90 days. Bristol-Myers Squibb is related to or competes with Roche Holding, Roche Holding, Roche Holding, AstraZeneca PLC, Novartis, Sanofi, and GSK Plc. Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical pro... More
Bristol-Myers Squibb Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bristol-Myers Squibb's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bristol Myers Squibb upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bristol-Myers Squibb's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bristol-Myers Squibb's standard deviation. In reality, there are many statistical measures that can use Bristol-Myers Squibb historical prices to predict the future Bristol-Myers Squibb's volatility.
Bristol-Myers Squibb appears to be very steady, given 3 months investment horizon. Bristol Myers Squibb secures Sharpe Ratio (or Efficiency) of 0.18, which signifies that the company had a 0.18 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Bristol Myers Squibb, which you can use to evaluate the volatility of the firm. Please makes use of Bristol-Myers Squibb's Risk Adjusted Performance of 0.124, mean deviation of 1.09, and Downside Deviation of 3.88 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Bristol-Myers Squibb holds a performance score of 14. The firm shows a Beta (market volatility) of 0.0817, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Bristol-Myers Squibb's returns are expected to increase less than the market. However, during the bear market, the loss of holding Bristol-Myers Squibb is expected to be smaller as well. Please check Bristol-Myers Squibb's potential upside, and the relationship between the total risk alpha and kurtosis , to make a quick decision on whether Bristol-Myers Squibb's price patterns will revert.
Auto-correlation
0.17
Very weak predictability
Bristol Myers Squibb has very weak predictability. Overlapping area represents the amount of predictability between Bristol-Myers Squibb time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bristol Myers Squibb price movement. The serial correlation of 0.17 indicates that over 17.0% of current Bristol-Myers Squibb price fluctuation can be explain by its past prices.
Correlation Coefficient
0.17
Spearman Rank Test
0.5
Residual Average
0.0
Price Variance
2262.36
Pair Trading with Bristol-Myers Squibb
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bristol-Myers Squibb position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol-Myers Squibb will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Bristol-Myers Squibb could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bristol-Myers Squibb when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bristol-Myers Squibb - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bristol Myers Squibb to buy it.
The correlation of Bristol-Myers Squibb is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bristol-Myers Squibb moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bristol Myers Squibb moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bristol-Myers Squibb can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Additional Tools for Bristol-Myers Pink Sheet Analysis
When running Bristol-Myers Squibb's price analysis, check to measure Bristol-Myers Squibb's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol-Myers Squibb is operating at the current time. Most of Bristol-Myers Squibb's value examination focuses on studying past and present price action to predict the probability of Bristol-Myers Squibb's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol-Myers Squibb's price. Additionally, you may evaluate how the addition of Bristol-Myers Squibb to your portfolios can decrease your overall portfolio volatility.